Neurology

MS cognitive screening tool able to predict actual functional performance.

Questions still persist regarding immunologic mechanisms of MS treatments and vitamin D.

Study may lead to vaccines that force an immune response.

Some patients with MS received a benefit from natalizumab involving the reduction of relapses and new MRI lesions.

A woman's hormonal status may resume balance.

Processing speed linked to both activity and participation among patients with MS.

Treatment with Zinbryta caused reductions in the risk of 24-week confirmed multiple sclerosis disability progression.

MS prevalence increases in areas of higher latitude with decreased levels of sunlight exposure.

MS-related inflammation may affect fertility.

Health information sharing web site helps connect patients among more than 2500 conditions.

Tecfidera reduces annualized MS relapse rate by 63% compared with placebo.

Researchers examine the correlation between vitamin D levels and MS risk in African Americans or Hispanics.

Cladribine was previously denied market authorization on the suspicion that it may cause cancer.

Sleep-wake cycle may link to exacerbated MS symptoms.

Ocrelizumab found to decrease progression of clinical disability.

Sleep disturbances accounted for a quarter of the variance in fatigue among patients with MS.

Each additional year of smoking after multiple sclerosis diagnosis accelerated the time to secondary progressive disease conversion.

MS patients who participate in physical activity more likely to have lower overall amount of brain lesions.

MS advocacy group provides a wide range of services that help patients manage the disease.

Physical and mental impairments prevent MS patients from being engaged in social and community activities.

Participation in social activities found to improve patient quality-of-life.

Exclusively breastfeeding may diminish MS relapse in the first 6 months after giving birth.

Multiple sclerosis advocate discusses the difficulties patients face during treatment.

Researchers still seek to determine if vitamin D can make any difference in the course of MS after onset.

Study finds a pattern of disconnectivity among executive areas of the brain.